Childestone et al. [85] observed anti-FMDV CD8+ activity five weeks pi, having proposed that CD8+ lymphocytes participate during the infection’s late phase, bearing in mind that FMDV is a cytopathic virus, and it is thus unlikely that a CD8+-type response would occur during the disease’s acute phase. This evidence concerns the gene CD8A and infection.